Floatz logo

Metformin

Adult Acute Myeloid Leukemia With Del(5q)

Northwestern UniversitySmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Adult Acute Myeloid Leukemia With Del(5q) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Alice Mims
Phase 3BBB
Cytosin-Arabinosid
Alice Mims
Phase 3BBB
Idarubicine
Bruno C. Medeiros
Phase 2BBB
Cyclophosphamide
Sumithira Vasu
Phase 3BBB
Fludarabine
Rutgers, The State University of New Jersey
Phase 3BBB

View all 50 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →